tradingkey.logo

InspireMD Inc

NSPR
View Detailed Chart

2.690USD

-0.060-2.15%
Close 08/01, 16:00ETQuotes delayed by 15 min
80.03MMarket Cap
LossP/E TTM

InspireMD Inc

2.690

-0.060-2.15%
Intraday
1m
30m
1h
D
W
M
D

Today

-2.15%

5 Days

+10.69%

1 Month

+20.09%

6 Months

+7.60%

Year to Date

+2.28%

1 Year

-9.43%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 2 analysts
BUY
Current Rating
4.500
Target Price
67.29%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

117
Total
6
Median
8
Average
Company name
Ratings
Analysts
InspireMD Inc
NSPR
2
Medtronic PLC
MDT
35
Stryker Corp
SYK
33
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
30
Dexcom Inc
DXCM
28
1
2
3
...
24

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Buy
Sell(1)
Neutral(2)
Buy(10)
Indicators
Sell(1)
Neutral(2)
Buy(4)
Indicators
Value
Direction
MACD(12,26,9)
0.066
Buy
RSI(14)
62.814
Neutral
STOCH(KDJ)(9,3,3)
65.525
Neutral
ATR(14)
0.165
High Vlolatility
CCI(14)
187.362
Buy
Williams %R
33.814
Buy
TRIX(12,20)
0.271
Sell
StochRSI(14)
69.549
Buy
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
2.546
Buy
MA10
2.511
Buy
MA20
2.430
Buy
MA50
2.420
Buy
MA100
2.512
Buy
MA200
2.640
Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.
Ticker SymbolNSPR
CompanyInspireMD Inc
CEOMr. Marvin L. Slosman
Websitehttps://www.inspiremd.com/en/
KeyAI